The hemostatic role of factor XI

Thrombosis Research

Volumn 141, Issue , 2016, Pages S8-S11

  Puy, Cristina ^a,b   Rigg, Rachel A ^a   McCarty, Owen J T ^a,b  

^a Oregon Health and Science University Department of Biomedical Engineering   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

bleeding; coagulation factor XI; coagulation factor XII; contact activation pathway; hemophilia C; hemostasis

Indexed keywords

BLOOD CLOTTING FACTOR 11; ANTICOAGULANT AGENT;

ARTICLE; BLOOD CLOTTING FACTOR 11 DEFICIENCY; HEMOSTASIS; HUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; THROMBOSIS; ANIMAL; BLOOD; BLOOD CLOTTING; COMPLICATION; DRUG DEVELOPMENT; DRUG EFFECTS; FACTOR XI DEFICIENCY; HEMORRHAGE; METABOLISM;

ANIMALS; ANTICOAGULANTS; BLOOD COAGULATION; DRUG DISCOVERY; FACTOR XI; FACTOR XI DEFICIENCY; HEMORRHAGE; HEMOSTASIS; HUMANS; THROMBOSIS;

EID: 84989855590     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/S0049-3848(16)30354-1     Document Type: Article

References (33)

1. 1 Schmaier, AH, Physiologic activities of the contact activation system. Thromb Res 133:Suppl (2014), S41–S44.
2. 2 Mackman, N, Tilley, RE, Key, NS, Role of the extrinsic pathway of blood coagulation in hemostasis and thrombosis. Arter Thromb Vasc Biol 27 (2007), 1687–1693.
3. 3 Cheng, Q, Tucker, EI, Pine, MS, Sisler, I, Matafonov, A, Sun, M-F, White-Adams, TC, Smith, SA, Hanson, SR, McCarty, OJT, Renné, T, Gruber, A, Gailani, D, A role for factor XIIa-mediated factor XI activation in thrombus formation in vivo. Blood 116 (2010), 3981–3989.
4. 4 Kravtsov, D V, Matafonov, A, Tucker, EI, Sun, M-F, Walsh, PN, Gruber, A, Gailani, D, Factor XI contributes to thrombin generation in the absence of factor XII. Blood 114 (2009), 452–458.
5. 5 Gailani, D, Broze, GJ, Factor XI activation in a revised model of blood coagulation. Science 253 (1991), 909–912.
6. 6 Matafonov, A, Cheng, Q, Geng, Y, Verhamme, IM, Umunakwe, O, Tucker, EI, Sun, M-F, Serebrov, V, Gruber, A, Gailani, D, Evidence for factor IX-independent roles for factor XIa in blood coagulation. J Thromb Haemost 11 (2013), 2118–2127.
7. 7 Puy, C, Tucker, EI, Wong, ZC, Gailani, D, Smith, SA, Choi, SH, Morrissey, JH, Gruber, A, McCarty, OJT, Factor XII promotes blood coagulation independent of factor XI in the presence of long chain polyphosphate. J Thromb Haemost 11 (2013), 1341–1352.
8. 8 Whelihan, MF, Orfeo, T, Gissel, MT, Mann, KG, Coagulation procofactor activation by factor XIa. J Thromb Haemost 8 (2010), 1532–1539.
9. 9 Puy, C, Tucker, EI, Matafonov, A, Cheng, Q, Zientek, KD, Gailani, D, Gruber, A, McCarty, OJT, Activated factor XI increases the procoagulant activity of the extrinsic pathway by inactivating tissue factor pathway inhibitor. Blood 125 (2015), 1488–1496.
10. 10 Baugh, RJ, Broze, GJ, Krishnaswamy, S, Regulation of extrinsic pathway factor Xa formation by tissue factor pathway inhibitor. J Biol Chem 273 (1998), 4378–4386.
11. 11 Geng, Y, Verhamme, IM, Smith, SB, Sun, M-F, Matafonov, A, Cheng, Q, Smith, SA, Morrissey, JH, Gailani, D, The dimeric structure of factor XI and zymogen activation. Blood 121 (2013), 3962–3969.
12. 12 Choi, SH, Smith, SA, Morrissey, JH, Polyphosphate is a cofactor for the activation of factor XI by thrombin. Blood 118 (2011), 6963–6970.
13. 13 Choi, SH, Smith, SA, Morrissey, JH, Polyphosphate accelerates factor V activation by factor XIa. Thromb Haemost 113 (2015), 599–604.
14. 14 Zhu, S, Travers, RJ, Morrissey, JH, Diamond, SL, FXIa and platelet polyphosphate as therapeutic targets during human blood clotting on collagen/tissue factor surfaces under flow. Blood 126 (2015), 1494–1502.
15. 15 Seligsohn, U, Factor XI deficiency in humans. J Thromb Haemost 7:Suppl 1 (2009), 84–87.
16. 16 Pike, GN, Cumming, AM, Hay, CRM, Bolton-Maggs, PHB, Burthem, J, Sample conditions determine the ability of thrombin generation parameters to identify bleeding phenotype in FXI deficiency. Blood 126 (2015), 397–405.
17. 17 Maroney, SA, Cooley, BC, Ferrel, JP, Bonesho, CE, Nielsen, L V, Johansen, PB, Hermit, MB, Petersen, LC, Mast, AE, Absence of hematopoietic tissue factor pathway inhibitor mitigates bleeding in mice with hemophilia. Proc Natl Acad Sci USA 109 (2012), 3927–3931.
18. 18 Vincent, LM, Tran, S, Livaja, R, Bensend, TA, Milewicz, DM, Dahlbäck, B, Coagulation factor V(A2440G) causes east Texas bleeding disorder via TFPIα. J Clin Invest 123 (2013), 3777–3787.
19. 19 Zucker, M, Seligsohn, U, Salomon, O, Wolberg, AS, Abnormal plasma clot structure and stability distinguish bleeding risk in patients with severe factor XI deficiency. J Thromb Haemost 12 (2014), 1121–1130.
20. 20 Langhauser, F, Göb, E, Kraft, P, Geis, C, Schmitt, J, Brede, M, Göbel, K, Helluy, X, Pham, M, Bendszus, M, Jakob, P, Stoll, G, Meuth, SG, Nieswandt, B, McKrae, KR, Kleinschnitz, C, Kininogen deficiency protects from ischemic neurodegeneration in mice by reducing thrombosis, blood-brain-barrier damage and inflammation. Blood 120 (2012), 4082–4092.
21. 21 Revenko, AS, Gao, D, Crosby, JR, Bhattacharjee, G, Zhao, C, May, C, Gailani, D, Monia, BP, MacLeod, AR, Selective depletion of plasma prekallikrein or coagulation factor XII inhibits thrombosis in mice without increased risk of bleeding. Blood 118 (2011), 5302–5311.
22. 22 Renné, T, Pozgajová, M, Grüner, S, Schuh, K, Pauer, H-U, Burfeind, P, Gailani, D, Nieswandt, B, Defective thrombus formation in mice lacking coagulation factor XII. J Exp Med 202 (2005), 271–281.
23. 23 Wang, X, Cheng, Q, Xu, L, Feuerstein, GZ, Hsu, M-Y, Smith, PL, Seiffert, DA, Schumacher, WA, Ogletree, ML, Gailani, D, Effects of factor IX or factor XI deficiency on ferric chloride-induced carotid artery occlusion in mice. J Thromb Haemost 3 (2005), 695–702.
24. 24 Salomon, O, Steinberg, DM, Zucker, M, Varon, D, Zivelin, A, Seligsohn, U, Patients with severe factor XI deficiency have a reduced incidence of deep-vein thrombosis. Thromb Haemost 105 (2011), 269–273.
25. 25 Salomon, O, Steinberg, DM, Koren-Morag, N, Tanne, D, Seligsohn, U, Reduced incidence of ischemic stroke in patients with severe factor XI deficiency. Blood 111 (2008), 4113–4117.
26. 26 Meijers, JC, Tekelenburg, WL, Bouma, BN, Bertina, RM, Rosendaal, FR, High levels of coagulation factor XI as a risk factor for venous thrombosis. N Engl J Med 342 (2000), 696–701.
27. 27 Yang, DT, Flanders, MM, Kim, H, Rodgers, GM, Elevated factor XI activity levels are associated with an increased odds ratio for cerebrovascular events. Am J Clin Pathol 126 (2006), 411–415.
28. 28 Büller, HR, Bethune, C, Bhanot, S, Gailani, D, Monia, BP, Raskob, GE, Segers, A, Verhamme, P, Weitz, JI, Factor XI Antisense Oligonucleotide for Prevention of Venous Thrombosis. N Engl J Med 372 (2014), 232–240.
29. 29 Von Brühl, ML, Stark, K, Steinhart, A, Chandraratne, S, Konrad, I, Lorenz, M, Khandoga, A, Tirniceriu, A, Coletti, R, Köllnberger, M, Byrne, RA, Laitinen, I, Walch, A, Brill, A, Pfeiler, S, Manukyan, D, Braun, S, Lange, P, Riegger, J, Ware, J, et al. Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. J Exp Med 209 (2012), 819–835.
30. 30 Gruber, A, Hanson, SR, Factor XI-dependence of surface- and tissue factor-initiated thrombus propagation in primates. Blood 102 (2003), 953–955.
31. 31 Geng, Y, Verhamme, IM, Smith, SA, Cheng, Q, Sun, M, Sheehan, JP, Morrissey, JH, Gailani, D, Factor XI anion-binding sites are required for productive interactions with polyphosphate. J Thromb Haemost 11 (2013), 2020–2028.
32. 32 Wong, PC, Quan, ML, Watson, CA, Crain, EJ, Harpel, MR, Rendina, AR, Luettgen, JM, Wexler, RR, Schumacher, WA, Seiffert, DA, In vitro, antithrombotic and bleeding time studies of BMS-654457, a small-molecule, reversible and direct inhibitor of factor XIa. J Thromb Thrombolysis 40 (2015), 416–423.
33. 33 Karuturi, R, Al-Horani, RA, Mehta, SC, Gailani, D, Desai, UR, Discovery of allosteric modulators of factor XIa by targeting hydrophobic domains adjacent to its heparin-binding site. J Med Chem 56 (2013), 2415–2428.